Merck, Pfizer receive FDA Breakthrough Therapy status for avelumab in metastatic MCC: New York Friday, November 20, 2015, 10:00 Hrs [IST] Merck KGaA, Darmstadt, Germany, and Pfize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback